ATRC•benzinga•January 13, 2025 at 01:42 PM

AtriCure Announces Q4 2024 Preliminary Revenue Of $124.3M, Up 17%, And FY Revenue Of $465.3M, U.S. Revenue Up 14% To $101.6M, International Revenue Increased 28% To $22.7M; Forecasted 2024 Adjusted EBITDA Is $26M-$29M And Adjusted Loss Per Share Is $0.74-

No summary available.

Read the full article from the original source for complete details and context.

Article published on January 13, 2025 by benzinga